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Abstract
Stored memories are dynamic and, when reactivated, can undergo a process of destabilization and reconsoli-
dation to update them with new information. Reconsolidation has been shown for a variety of experimental
settings; most recently for well-learned instrumental memories, a class of memory previously thought not to
undergo reconsolidation. Here we tested, in rats, whether a weakly-trained lever-pressing memory destabilized
following a shift in reinforcement contingency. We show that lever-pressing memory for both sucrose and cocaine
reinforcement destabilized under appropriate conditions, and that the reconsolidation of this memory was
impaired by systemic administration of the NMDA receptor (NMDAR) antagonist [5R,10S]-[]-5-methyl-10,1-
dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801). We went on to investigate the potential role of the
nucleus accumbens (NAc) in the reconsolidation of sucrose-reinforced instrumental memories, showing that
co-infusion of the NMDAR antagonist 2-amino-5-phosphonopentanoic acid (AP-5) and the dopamine-1 receptor
(D1R) antagonist 7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol (SCH23390) into the NAc
prior to memory reactivation impaired reconsolidation; however, there was no effect when these drugs were
infused alone. Further investigation of this effect suggests the combined infusion disrupted the reconsolidation of
pavlovian components of memory, and we hypothesize that coactivation of accumbal D1Rs and NMDARs may
contribute to both the destabilization and reconsolidation of appetitive memory. Our work demonstrates that
weakly-trained instrumental memories undergo reconsolidation under similar parameters to well-trained ones,
and also suggests that receptor coactivation in the NAc may contribute to memory destabilization. Furthermore,
it provides an important demonstration of the therapeutic potential of reconsolidation-based treatments that
target the instrumental components of memory in maladaptive drug seeking.
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Significance Statement
This research adds to the growing body of evidence that instrumental memories (memories of interactions
with the world) undergo reconsolidation, a class of memory previously not thought to undergo reconsoli-
dation. Furthermore, we suggest that there may be a role for coactivation of accumbal D1Rs and NMDARs
in the destabilization and reconsolidation of appetitive memory. Our work also extends to include recon-
solidation disruption of responding for cocaine self-administration. This provides proof of principle that
impairing the reconsolidation of instrumental memory can diminish the instrumental components of drug
seeking, and demonstrates the potential viability of reconsolidation-based therapies for maladaptive
memory disorders.
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Introduction
Following an initial phase of consolidation, memories exist
in a stable state, resistant to amnesic intervention (Mc-
Gaugh, 2000). Memories are not fixed, however, and can
be destabilized, rendering them labile to be updated with
new information (Lee, 2009). In order to persist following
destabilization, memories must undergo a process of re-
consolidation that returns them to their stable form (Na-
der, 2003). Reconsolidation has been demonstrated for
nearly all types of memory (for review, see Reichelt and
Lee, 2013) and its initiation (via destabilization) appears to
require a prediction error (Sevenster et al., 2013).
A notable cluster of negative findings within the field of
reconsolidation have concerned instrumental memories,
raising questions over whether reconsolidation is a uni-
versal process for memory persistence. Early studies ob-
served that the instrumental components of sucrose
(Hernandez and Kelley, 2004), saccharine (Mierzejewski
et al., 2009), and cocaine (Brown et al., 2008) self-
administration did not appear to undergo reconsolidation,
although pavlovian memories associated with these be-
haviours did (Lee et al., 2006a; Milton et al., 2008b).
Recently, instrumental memory underpinning well-learned
sucrose seeking was shown to undergo reconsolidation
(Exton-McGuinness et al., 2014b), and subsequently lever
pressing for nicotine was also shown to undergo recon-
solidation (Tedesco et al., 2014; although this result may
not represent reconsolidation of the instrumental compo-
nent of memory, see Exton-McGuinness et al., 2014a).
We first sought to investigate whether a weakly-trained
instrumental memory would destabilize following a
change in reinforcement contingency, from a fixed to a
variable ratio schedule, as was recently demonstrated to
be the case in a well-trained setting (Exton-McGuinness
et al., 2014b). While it is an obvious prediction that both
weakly and well-learned memories should be destabilized
according to similar principles, it is well acknowledged
that instrumental behaviors become automated with over-
training (Dickinson, 1985), becoming reliant on neural sys-
tems that are distinct from those used early on in training
(Balleine and O’Doherty, 2010). Furthermore, older (Su-
zuki et al., 2004) and more extensively trained memories
(Suzuki et al., 2004; Reichelt and Lee, 2012) generally
require different reactivation parameters in order to de-
stabilize (typically longer or more frequent stimulus pre-
sentation) compared to those that are sufficient following
a more limited training regimen. These more extreme
reactivation parameters could lead to extinction learning
in which responding is suppressed by a new inhibitory
memory (Bouton, 2002), rather than reconsolidation
whereby the original memory is updated, when used with
a younger, weaker memory (Reichelt and Lee, 2012).
Thus, we elected to use a lesser shift in contingency to
destabilize weakly-trained lever-pressing memory than
was used previously in a well-trained setting (Exton-
McGuinness et al., 2014b).
We also explored whether brief non-reinforced or train-
ing reactivations could destabilize lever-pressing mem-
ory. These additional reactivation parameters also acted
to test the necessity for reinforcer presentation during
reactivation, as the presence and consumption of the
reinforcer may provide both external and internal stimuli,
which contribute to memory destabilization (Milekic et al.,
2006; Valjent et al., 2006; Brown et al., 2008). The efficacy
of the reactivation conditions to destabilize instrumental
memory and initiate reconsolidation was initially verified
using systemic injections of the NMDAR antagonist MK-
801, shown previously to disrupt reconsolidation of instru-
mental memory (Exton-McGuinness et al., 2014b).
We then progressed to intra-NAc infusions of AP-5 and
SCH23390 in order to assess any potential role for local
activation of D1Rs and NMDARs in the reconsolidation of
instrumental memories, as coactivation of these receptors in
the NAc is implicated in the acquisition of lever pressing
(Smith-Roe and Kelley, 2000). We also infused MK-801 to
determine whether the NAc was a central locus of action for
systemic treatment. The NAc has been strongly implicated in
mediating reward-seeking behaviors and is a key hub in the
reward circuitry disrupted by addictive drugs such as co-
caine (Robbins and Everitt, 1996; Loweth et al., 2014).
Disruption of reconsolidationmay offer a novel therapeutic
intervention for maladaptive memories, such as post-
traumatic stress disorder (Pitman, 2011) and drug addiction
(Milton, 2013). In order to demonstrate the translational ben-
efit of disrupting instrumental memory reconsolidation, we
tested whether lever pressing for cocaine self-administration
would undergo reconsolidation following a shift in reward
contingency. While a previous study showed MK-801 did
not disrupt the reconsolidation of cocaine self-
administration (Brown et al., 2008), we hypothesized this
was due to inappropriate, or insufficient, reactivation param-
eters. Appetitive pavlovian memory for both sucrose and
cocaine undergoes reconsolidation (Lee et al., 2006a; Milton
et al., 2008b), and so it seemed logical that any successful
impairment of sucrose-reinforced instrumental memory re-
consolidation would translate to a cocaine self-
administration setting.
Materials and Methods
Subjects
Subjects were 219 experimentally naïve adult male
lister hooded rats (Charles River), aged 6-8 weeks (me-
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dian 6 weeks) and weighing 200-350 g (median 250 g) at
the start of the experiment. Rats were housed in
individually-ventilated cages of 4 at 21 °C on a 12 h
light-dark cycle (lights on at 0700) in a specialist animal
facility. Individually-ventilated cages contained aspen
chip bedding, and environmental enrichment was avail-
able in the form of a Plexiglass tunnel. Experiments took
place in a behavioral laboratory between 0800 and 1200.
Rats in the sucrose studies were fed a restricted diet of 15
g chow per day for the duration of the behavioral proce-
dures (this was supplemented by any sucrose rewards
obtained during the study); weights were regularly re-
corded and assessed against an in-house growth chart.
Rats in the cocaine study had freely available food. Water
was freely available except during experimental proce-
dures. At the end of the experiment, animals were hu-
manely killed via a rising concentration of CO2; death was
confirmed by cessation of heartbeat. All procedures were
approved by a local ethical review committee and carried
out in accordance with the United Kingdom 1986 Animals
(Scientific Procedures) Act (PPLs 40/3205 & 70/7662).
Surgical procedures
All surgeries were performed aseptically in accordance
with the LASA guiding principles for aseptic surgery
(LASA, 2010). Rats were anaesthetized using isoflurane
(5% for induction, 2-3% for maintenance), and adminis-
tered peri-operative buprenorphine. Post-surgery, rats
were housed individually with Puracel bedding overnight
before being rehoused with their cage mates the next
morning. Their diet was also supplemented with the non-
steroidal anti-inflammatory Carprofen for 2 d post-
operatively. A minimum of 5 d recovery was allowed
before experimental procedures began.
Eighty rats were implanted bilaterally with stainless
steel cannulae (11 mm, 22 gauge; Coopers Needleworks).
Cannulae were directed at the NAc region of the brain
using a stereotaxic frame: AP 1.5 mm, ML 1.8 mm
from bregma, DV 1.8 mm from skull surface (Paxinos
and Watson, 2009). Stainless steel stylets extending 1
mm past the end of the guide cannulae were inserted
post-surgery in order to maintain patency until infusion.
Prior to reactivation, stylets were removed and injectors
(28 gauge; Plastics One) inserted into the guide cannulae,
extending 6 mm past the end of the guide cannulae to a
final DV 7.8 mm. PBS vehicle, MK-801, AP-5,
SCH23390, or combined AP-5/SCH23390 (see Drugs,
below) was infused into the NAc immediately prior to
reactivation. At the end of the experiment, cannulated rats
were killed, their brains extracted freshly and fixed in 4%
paraformaldehyde. Brains were sectioned then stained
using cresyl violet and the locations of injectors confirmed
using light microscopy (Fig. 1).
For the cocaine study, 12 rats were catheterized by
Charles River and an additional 20 were implanted with
intravenous catheters based on previous literature (Di
Ciano and Everitt, 2001; Lee et al., 2006a). Briefly, rats
were implanted with a single catheter (Camcaths) in the
right jugular vein aimed at the left vena cava. The mesh
end of the catheter was sutured subcutaneously on the
dorsum.
Drugs
For the sucrose and cocaine self-administration studies,
MK-801 (AbCam) was dissolved in sterile saline to a
concentration of 0.1 mg/ml. Thirty minutes prior to the
reactivation session, rats were administered intraperito-
neally with 0.1 mg/kg of MK-801 or equivalent volume of
saline vehicle. This dose of systemic MK-801 has previ-
ously been shown to disrupt instrumental memory recon-
solidation (Exton-McGuinness et al., 2014b). Injections
were carried out systematically by cage, randomly within
each cage.
For intracerebral infusions, all drugs were dissolved in
sterile PBS. AP-5 (AbCam), SCH23390 (RBI), and MK-801
were made to a concentration of 1 g/0.5 l. The com-
bined AP-5/SCH23390 solution was made up to 0.1 g/
0.5 l of each AP-5 and SCH23390. The choice of drugs
and dosages were based on those shown previously to
disrupt acquisition of lever pressing (Kelley et al., 1997;
Smith-Roe and Kelley, 2000). Infusions were given sys-
tematically by cage, randomly within each cage. Immedi-
ately prior to the memory reactivation session, stylets
were removed and injectors were inserted into the guide
cannulae. Using a microdrive syringe pump (Harvard Ap-
paratus), 0.5 l of drug or PBS vehicle control was infused
at a rate of 0.5 l/min. Injectors were left in place for 1 min
after the infusion to allow diffusion of the drug. Infusions
were given immediately before, rather than after, reacti-
vation as past work has shown that pre-session (Kelley
et al., 1997; Smith-Roe and Kelley, 2000) but not post-
session (Hernandez et al., 2005) infusions of AP-5 or
SCH23390 into the NAc core impair instrumental acqui-
sition. Moreover, the time window of vulnerability of re-
consolidation to disruption appears to be more limited
than for consolidation (Judge and Quartermain, 1982).
For cocaine self-administration, cocaine (Sigma-
Aldrich) was dissolved in sterile saline to a concentration
of 2.5 mg/ml; intravenous infusions of 0.1 ml over 5 s
could be obtained during training and reactivation. Drug
infusion dosage was based on previous literature (Di
Ciano and Everitt, 2001).
Behavioural apparatus
Training, memory reactivation, and testing sessions took
place in eight operant boxes (MedAssociates) measuring
25  32  25.5 cm, each housed individually within a
sound-attenuating chamber. The rear wall and door were
made of Perspex, the other two walls of metal. The boxes
contained a grid floor of 19 evenly spaced, stainless steel
bars (4.8 mm diameter), underneath which was a remov-
able tray. A nosepoke magazine was mounted on the
right-hand wall into which the reward pellets could be
delivered, flanked on either side by two retractable levers.
The magazine contained an infrared detector that re-
corded magazine entries (nosepokes). The box was illu-
minated by a small houselight mounted on the upper
left-hand wall, which came on at the start of each exper-
imental session and switched off at the end. Two boxes
were equipped with an infusion pump and drug delivery
New Research 3 of 17
March/April 2015, 2(2) e0009-15.2015 eNeuro.sfn.org
arm assembly (MedAssociates) for the intravenous deliv-
ery of cocaine. The operant boxes were run from a local
computer using specialized computer software (MedAs-
sociates), which also recorded behavioral responses (le-
ver presses and nosepokes).
Training procedures
Sucrose study
Rats were initially trained to collect 45 mg sucrose reward
pellets (TestDiet) from the magazine. Pellets were deliv-
ered at random intervals (mean 60 s) for 15 min. This
pre-training facilitated instrumental learning over the lim-
ited training schedule. Instrumental training began imme-
diately after the pre-training session. On the first training
day, a single lever was extended into the box and deliv-
ered a sucrose pellet into the magazine when pressed, on
a fixed-ratio (FR1; one lever press delivers one pellet)
schedule; responses on the lever had no other pro-
grammed consequence, the lever did not retract and
remained extended throughout the session and no dis-
crete stimuli were presented at any point during training.
A maximum of 30 pellets could be obtained; the session
ended when the maximum number of pellets had been
obtained or 30 min elapsed. Rats received a second 30
min training session the next day with a maximum of 60
pellets obtainable and this marked the end of the training
phase. Rats were injected systemically with MK-801 30
min prior to the memory reactivation session.
Intra-accumbans study
Behavioral procedures were carried out as in the sucrose
study. Rats were implanted with bilateral cannualae
aimed at the NAc (see Surgical procedures, above) and
drugs were infused immediately before reactivation.
Cocaine study
Prior to each training or reactivation session, the im-
planted intravenous catheter (see Surgical procedures,
above) was connected to the infusion arm. For the pre-
operated rats, this was achieved using a vascular access
harness and tether (Instech). For the rats catheterized
in-house, the catheter was connected directly to the
spring tether (Camcaths). A single lever was extended into
the chamber at the start of each session. Rats were
trained to lever press for cocaine on an FR1 schedule. A
Figure 1 Schematic of the brain. Black dots indicate the location of injector tips for reactivated PBS (A), AP-5 (B), SCH23390 (C),
AP-5/SCH23390 (D), MK-801 (E) infused groups and non-reactivated PBS (F), and AP-5/SCH23390 (G) controls. H, Diagram showing
location of notable brain regions surrounding the infusion site. Numbers (right) signify millimeters from bregma. All injectors were
located within the NAc.
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maximum of 30 intravenous cocaine infusions could be
obtained on the first training day and 60 on the second;
each session lasted a maximum of 2 h. After each infu-
sion, there was an enforced time-out of 20 s before the
next infusion could be obtained. The lever retracted for
the duration of the time-out period. Rats did not receive
any pre-training for the cocaine study, nor were any dis-
crete reward-paired stimuli presented. Nosepokes had no
programmed consequence. Rats were injected systemi-
cally with MK-801 30 min prior to the memory reactivation
session.
Reactivation procedures
In the systemic studies, a variety of behavioral conditions
were tested for their efficacy to cause memory destabili-
zation.
VR5 reactivation
A variable number of lever presses (mean: 5, range: 1-9)
were required to obtain a reward. A maximum of 20
reinforcements could be obtained. The variable-ratio
(VR5; one pellet is delivered following a mean of five lever
presses) reactivation was also used for the intracerebral
and cocaine studies. For sucrose studies, the session
length was 20 min. For the cocaine study, the lever re-
tracted for 20 s, as in training, and the session length was
30 min. This reactivation was chosen based on a previous
finding that a variable-ratio schedule destabilized a well-
established instrumental memory (Exton-McGuinness
et al., 2014b).
Non-reactivation controls
Additional rats were used, which received systemic injec-
tion of MK-801 or coinfusion of AP-5/SCH23390 (or ap-
propriate vehicle control), but without a reactivation
session. This provided an important control for determin-
ing whether reconsolidation had been disrupted; amnes-
tic treatment in the absence of memory reactivation
should be without effect.
Non-reinforced reactivation
A very brief non-reinforced session lasted only 2 min; no
rewards were delivered during this session. Brief non-
reinforced sessions have been frequently used to desta-
bilize pavlovian memories in past studies (Lee et al.,
2006b; Milton et al., 2008b). In a previous study of well-
learned lever pressing for sucrose, a 5 min non-reinforced
session did not destabilize the instrumental memory
(Exton-McGuinness et al., 2014b); however, it may be
that a shorter non-reinforced reactivation could, as
briefer sessions typically favor reconsolidation, while
longer non-reinforced sessions usually lead to extinc-
tion (Flavell and Lee, 2013; Merlo et al., 2014), in which
a new memory is formed that suppresses behavioral
output (Bouton, 2002).
FR1 reactivation
A brief FR1 session was identical to that used in training
but curtailed to a maximum of 20 pellets, with a maximum
duration of 20 min. Training sessions have been shown to
trigger memory destabilization, however, only when the
memory is not well-learned (Rodriguez-Ortiz et al., 2005;
Díaz-Mataix et al., 2013; Exton-McGuinness et al., 2014a),
consistent with the hypothesis that reconsolidation serves
memory updating (Lee, 2009). As the lever-pressing mem-
ory used in our study was only weakly trained, we hypoth-
esized a training trial could also induce reconsolidation.
This session also tested whether it was the variability of
the VR5 reactivation contingency or simply the pres-
ence of the reinforcer that was the salient feature of the
VR5 reactivation. The presence of the unconditioned
stimulus is sometimes required to destabilize appetitive
pavlovian memory (Milekic et al., 2006; Valjent et al.,
2006), and furthermore the contingency of reinforcer
presentation may also be an important factor in deter-
mining whether a memory will destabilize (Lee and
Everitt, 2008a).
Testing procedures
Instrumental performance was tested the day after drug
treatment for all groups. Test sessions lasted 30 min and
were performed in extinction. The lever was extended, no
rewards were delivered, and the houselight remained on
throughout the session. The lever did not retract during
testing.
In the systemic sucrose study, one additional group of
rats received their test session 3 h after the VR5 reacti-
vation. This was done to assess any effect of the MK-801
on post-reactivation short-term memory (pr-STM). If pr-
STM was disrupted by MK-801, then it might imply that
MK-801 had effects other than disrupting long-term mem-
ory reconsolidation, which impacted on behavioral ex-
pression. Were the reconsolidation of long-term memory
disrupted by MK-801, then there should typically be no
effect on short-term memory expression.
Statistical analysis
Data are represented as mean  SEM throughout. Results
with p  0.05 were deemed significant. Statistical analyses
are summarized in Table 1 (superscript letters in the Results
text indicate rows in the table). Observed power was calcu-
lated post hoc with GPower 3.1 (Faul et al., 2007) using the
size of the highest order effect at test.
Experimental groups were matched for number of lever
presses made during training. Training data was analyzed
using repeated-measures ANOVA with Training Day and
Drug Group as factors in order to assess whether the task
was learned and whether groups were similarly per-
forming at the end of the training phase. Where appro-
priate, planned comparisons were performed on the
second day of training in order to test for any pre-
reactivation differences.
In the systemic experiments, reactivation and test ses-
sions were analyzed separately using one-way ANOVA for
rats given brief extinction or training sessions. For intra-
cerebral infusion groups, reactivation and test data was
compared to a single control using Bonferroni-corrected
planned comparisons (effective p  0.0125). Non-
reactivated rats were compared to their respective reac-
tivated counterparts using two-way ANOVA with
Reactivation and Drug Treatment as factors. Similar anal-
ysis was performed on all sessions for magazine entries
(nosepokes) in order to assess general activity. Differ-
ences in nosepokes may indicate differences in motiva-
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tion, which may have impacted lever-pressing
performance; however, it is important to note that, in the
case of the sucrose studies, the magazine also acted as a
reward location, which might have influenced the total
number of nosepokes made.
In the sucrose-seeking studies, rats that failed to obtain
at least 30 rewards on the second training day were
excluded from the final analysis due to insufficient learn-
ing. For cocaine seeking, rats obtaining fewer than five
rewards on the second day of training were excluded from
further analysis. These criteria excluded 40 rats from the
systemic sucrose experiments, 19 from the intracerebral
study, and four from the cocaine study. Four rats were
killed following surgical complications and did not start
the experiment. Eleven rats had bent or blocked cannulae
and were excluded from analysis as they did not receive
bilateral infusions. An additional vehicle-treated rat was
excluded from the analysis of the cocaine study as his
data point lay more than 2 SDs from the group mean.
Results
Sucrose study
VR5 reactivation
We first tested whether a briefly-trained instrumental
memory for sucrose reinforcement would destabilize fol-
lowing the VR5 reactivation, a session in which a variable
number of lever presses were required to obtain a reward.
If the memory was successfully destabilized, then its sub-
sequent reconsolidation should be disrupted by systemic
MK-801, leading to a reduction in long-term memory
expression.
Treatment groups showed similar acquisition of lever
pressing over the 2 d of training, confirming that rats
learned to press the lever to acquire sucrose and that
groups were well matched (data not shown; Training:
F(1,27) 1244.0, p 0.001
a; Treatment: F(1,27) 0.02, p
0.895a; Reactivation: F(1,27) 1.61, p 0.215
a; Treatment
 Reactivation: F(1,27)  0.17, p  0.684
a; Training 
Table 1: Summary of statistical analyses. Letters (left) refer to values within the Results section. Observed power was
calculated using the highest order effect size at test.
Data structure Type of test Observed power
a Normally distributed Repeated measures ANOVA 0.959
b Normally distributed One-way ANOVA 0.333
c Normally distributed Two-way ANOVA with post hoc simple effects 0.596
d Normally distributed Repeated-measures ANOVA with post hoc comparisons 0.077
e Normally distributed One-way ANOVA 0.056
f Normally distributed Two-way ANOVA 0.063
g Normally distributed Repeated-measures ANOVA 0.230
h Normally distributed One-way ANOVA 0.094
i Normally distributed Two-way ANOVA 0.094
j Normally distributed Repeated-measures ANOVA 0.878
k Normally distributed One-way ANOVA 0.347
l Normally distributed One-way ANOVA 0.347
m Normally distributed Repeated-measures ANOVA with post hoc comparisons 1.000
n Normally distributed One-way ANOVA 0.812
o Normally distributed One-way ANOVA 0.812
p Normally distributed Repeated-measures ANOVA 0.644
q Normally distributed One-way ANOVA 0.215
r Normally distributed One-way ANOVA 0.215
s Normally distributed Repeated-measures ANOVA 0.470
t Normally distributed One-way ANOVA 0.157
u Normally distributed Repeated-measures ANOVA 0.050
v Normally distributed One-way ANOVA 0.050
w Normally distributed One-way ANOVA 0.050
x Normally distributed Repeated-measures ANOVA with Bonferroni-corrected planned comparisons 1.000
y Normally distributed One-way ANOVA with Bonferroni-corrected planned comparisons 0.734
z Normally distributed One-way ANOVA with Bonferroni-corrected planned comparisons 0.734
aa Normally distributed Repeated-measures ANOVA with Bonferroni-corrected planned comparisons 0.981
bb Normally distributed One-way ANOVA with Bonferroni-corrected planned comparisons 0.450
cc Normally distributed One-way ANOVA with Bonferroni-corrected planned comparisons 0.450
dd Normally distributed Repeated-measures ANOVA with post hoc comparisons 0.996
ee Normally distributed Two-way ANOVA with post hoc simple effects 0.776
ff Normally distributed Repeated-measures ANOVA 0.964
gg Normally distributed Two-way ANOVA with post hoc simple effects 0.620
hh Normally distributed Repeated-measures ANOVA 0.995
ii Normally distributed One-way ANOVA 0.477
jj Normally distributed Two-way ANOVA with post hoc simple effects 0.768
kk Normally distributed Repeated-measures ANOVA 0.061
ll Normally distributed One-way ANOVA 0.053
mm Normally distributed Two-way ANOVA 0.055
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Treatment: F(1,27)  2.48, p  0.128
a; Training  Reacti-
vation: F(1,27)  0.64, p  0.430
a; Training  Treatment 
Reactivation: F(1,27)  1.20, p  0.282
a). The day after
training, rats were administered systemic MK-801 or sa-
line control 30 min prior to the VR5 reactivation session.
There was no significant difference in lever pressing be-
tween MK-801- (100.1  5.2) and saline- (92.4  9.7)
treated groups during the VR5 memory reactivation ses-
sion (F(1,14)  0.56, p  0.468
b).
In a test of long-term memory, 24 h after drug admin-
istration and reactivation (Fig. 2A), there was a
reactivation-dependent effect of MK-801 on lever press-
ing (Treatment  Reactivation: F(1,27)  4.53, p  0.042
c)
with no significant main effects of treatment (F(1,27) 0.55,
p  0.464c) or reactivation (F(1,27)  0.01, p  0.908
c).
Analysis of simple main effects showed significantly re-
duced lever pressing in MK-801-treated reactivated rats
compared to reactivated saline controls (F(1,14)  6.02, p
 0.028c); however, there was no effect of drug treatment
in the non-reactivated groups (F(1,13)  0.71, p  0.415
c).
This suggests reconsolidation was impaired by systemic
MK-801, and by inference that the VR5 reactivation suc-
cessfully destabilized lever-pressing memory, as there
was no significant effect of MK-801 in the absence of
reactivation. Orthogonal simple effects showed no signif-
icant difference in lever pressing between reactivated and
non-reactivated saline- (F(1,13)  1.88, p  0.194
c) or
MK-801- (F(1,14)  2.91, p  0.110
c) treated animals.
In order to assess general activity during each session,
we also performed analysis on nosepoking behavior; any
reduction in nosepoking could indicate an impairment in
activity or motivation that might have impacted lever-
pressing performance independently of any putative in-
strumental memory reconsolidation deficit. Rats
significantly increased their nosepoking during training
(F(1,27)  126.28, p  0.001
d). There was also a significant
overall effect of reactivation condition (F(1,27)  4.69, p 
0.039d) with a significant Treatment  Reactivation inter-
action (F(1,27)  6.21, p  0.019
d). There were no other
significant group differences during training (Treatment:
F(1,27)  1.24, p2.76
d; Training  Treatment: F(1,27) 
2.35, p 0.137d; Training Reactivation: F(1,27) 0.40, p
 0.532d; Training  Treatment  Reactivation: F(1,27) 
0.03, p  0.869d). Analysis of the final training day did not
reveal any significant effect of drug treatment (F(1,27) 
0.20, p  0.655d), reactivation condition (F(1,27)  0.74, p
 0.396d), or interaction between the two (F(1,27) 2.74, p
 0.109d); therefore, groups displayed similar nosepoking
activity on the final day of training, suggesting similar
levels of motivation to respond prior to reactivation (data
not shown). During the VR5 reactivation, there was no
significant acute effect of MK-801 (274.4  39.2) on
nosepoking (F(1,14) 0.99, p 0.336
e) compared to saline
controls (223.3  28.7), nor was there any long-term
effect of drug treatment on nosepoking activity at test
(Fig. 2B; Treatment: F(1,27)  1.01, p  0.323
f; Reactiva-
tion: F(1,27)  1.03, p  0.320
f; Treatment  Reactivation:
F(1,27)  0.10, p  0.755
f), suggesting groups were simi-
larly active during testing.
pr-STM
An additional group of rats were trained, injected and
reactivated as above and their memory tested 3 h after
receiving the VR5 reactivation session in order to assess
pr-STM. This test controls for any effect of drug treatment
on behavioral expression, which may impact later long-
term recall. If an impairment in long-term memory is due
to disruption of reconsolidation, then short-term memory
should be intact. Both treatment groups learned to lever
press similarly during training (data not shown; Training:
F(1,14) 461.37, p 0.001
g; Treatment: F(1,14) 1.08, p
0.317g; Training  Treatment: F(1,14)  0.58, p  0.461
g).
There was no significant effect of MK-801 on lever-
pressing performance during either the VR5 reactivation
(Saline: 91.2  4.5; MK-801: 100.9  4.5; F(1,14)  2.24, p
 0.157h) or pr-STM test (Fig. 3A; F(1,14)  0.38, p 
0.548i). Thus, pr-STM was unimpaired by MK-801 treat-
ment prior to the VR5 reactivation.
Similar analysis was performed for nosepoking to con-
firm MK-801 had no significant effect on short-term be-
havioral expression. Nosepoking activity was similar in
both treatment groups during training (data not shown;
Figure 2 Systemic MK-801 impaired the reconsolidation of a
weakly-learned lever-pressing memory for sucrose reinforce-
ment following a shift to a VR5 schedule during reactivation. A,
MK-801 (n  9) administered prior to the VR5 reactivation sig-
nificantly impaired lever-pressing performance in a reactivation-
dependent manner at test the next day. Performance of
reactivated MK-801 rats was impaired compared to reactivated
saline controls (n  7); however, there was no significant differ-
ence between non-reactivated rats administered saline (n 8) or
MK-801 (n  7). B, MK-801 treatment had no significant effect
on long-term nosepoking behavior regardless of reactivation.
Data are represented as mean  SEM.
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Training: F(1,14)  9.47, p  0.008
j; Treatment: F(1,14) 
0.001, p  0.974j; Training  Treatment: F(1,14)  0.01, p
 0.927j). No acute effect of MK-801 was observed in
nosepoking activity during the VR5 reactivation (Saline:
245.8  19.6; MK-801: 238.3  20.2; F(1,14)  0.07, p 
0.797k), nor in the test of pr-STM (Fig. 3B; F(1,14)  2.47, p
 0.139l).
Non-reinforced reactivation
Following the success of the VR5 reactivation to destabi-
lize the briefly-trained lever-pressing memory, we next
sought to test for the necessity of reinforcer presentation
during reactivation. In many cases, pavlovian memories
have been successfully destabilized and their reconsoli-
dation disrupted using non-reinforced stimulus presenta-
tion (Lee et al., 2006b; Milton et al., 2008b). A recent study
found that non-reinforced reactivation did not destabilize
a well-learned instrumental memory (Exton-McGuinness
et al., 2014b). However, it remains possible that shorter
non-reinforced sessions could destabilize instrumental
memories. Session length plays an important part in de-
termining the switch between destabilization, leading to
memory updating, and extinction (Flavell and Lee, 2013;
Merlo et al., 2014), in which a new inhibitory memory
suppresses behavioral responding (Bouton, 2002).
During the training phase, repeated-measures ANOVA
revealed a significant effect of Training (F(1,12)  698.0, p
 0.001m), showing rats learned the lever-pressing task. A
Training  Treatment interaction (F(1,12)  5.04, p 
0.044m) was revealed with no main effect of Treatment
(F(1,12)  0.06, p  0.815
m). Analysis of the second day of
training showed no significant difference in lever pressing
(F(1,12)  1.49, p  0.245
m), indicating groups were simi-
larly performing at the end of training prior to reactivation
the next day (data not shown). ANOVA of the reactivation
session revealed a significant increase in lever pressing
following MK-801 injection (Saline: 5.1  1.7; MK-801:
16.3 2.6; F(1,12) 14.19, p 0.003
n), which persisted in
the test session 24 h later (Fig. 4A; F(1,12)  8.23, p 
0.014°).
Accompanying analysis of nosepoking showed rats sig-
nificantly increased their nosepoking over Training (F(1,12)
 31.45, p  0.001p) with no significant group differences
(data not shown; Treatment: F(1,12)  2.62, p  0.132
p;
Training  Treatment: F(1,12)  0.09, p  0.765
p), implying
similar activity levels prior to drug intervention and reac-
tivation. During reactivation, MK-801-injected rats nose-
poked significantly more than saline controls (Saline: 20.8
 4.8; MK-801: 36.5  3.0; F(1,12)  6.44, p  0.026
q);
however, this effect had dissipated by the test session
(Fig. 4B; F(1,12)  1.37, p  0.264
r).
FR1 reactivation
Given that the non-reinforced reactivation did not appear
to destabilize lever-pressing memory, allowing its recon-
solidation to be disrupted by MK-801, we next tested
Figure 3 Treatment with systemic MK-801 was without effect on
pr-STM. A, Three hours after reactivation MK-801 treated rats (n
 7) showed no significant difference in lever pressing compared
with vehicle controls (n  9). B, MK-801 had no significant effect
on short-term nosepoking behavior 3 h after reactivation. Data
are represented as mean number of lever presses  SEM.
Figure 4MK-801 impaired new extinction learning resulting from
the non-reinforced reactivation. A, MK-801-injected rats (n  6)
responded significantly more than saline controls at test (n  8).
B, MK-801 treatment had no significant effect on nosepoking at
test. Data are represented as mean number of lever presses 
SEM.
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whether the memory could be destabilized by a brief FR1
reactivation. In the case of memories that are not well-
learned, training trials have been used to destabilize
memory traces (Rodriguez-Ortiz et al., 2005; Exton-
McGuinness et al., 2014a). This session was fundamen-
tally equivalent to a short training session and also tested
for the sufficiency of reinforcer presentation in the desta-
bilization of lever-pressing memory.
Both treatment groups acquired similar levels of lever
pressing during training (data not shown; Training: F(1,10)
 341.8, p 0.001s; Treatment: F(1,10) 0.54, p 0.481
s;
Training  Treatment: F(1,10)  0.57, p  0.468
s). Rats
were then injected with MK-801 or saline, followed by the
FR1 reactivation session. During reactivation, all rats made
the maximum of 20 lever presses and acquired 20 sucrose
pellets each. The next day at test (Fig. 5A), there was no
significant difference in lever pressing between treatment
groups (F(1,10)  0.90, p 0.365
t), implying the FR1 session
did not destabilize the lever-pressing memory, preventing
MK-801 from disrupting its reconsolidation.
Companion analysis showed nosepoking to increase
through training (F(1,10)  41.53, p  0.001
u), with no signif-
icant difference between groups (data not shown; Treat-
ment: F(1,10) 0.46, p 0.514
u; Training Treatment: F(1,10)
 1.18, p  0.304u), nor were there any significant group
differences during reactivation (Saline: 84.7  9.5; MK-801:
119.3  14.7; F(1,10)  3.92, p  0.076
v) or the test session
(Fig. 5B; F(1,10)  0.004, p  0.949
w).
Intra-accumbans study
Drug infusions
Having established the ability of the VR5 reactivation to
destabilize the weakly-trained lever-pressing memory, we
next investigated the potential local involvement of accum-
bal NMDA and D1Rs in reconsolidation of lever-pressing
memory. Previous work has shown coactivation of NMDA
and D1Rs in the NAc to be involved in the acquisition of lever
pressing (Smith-Roe and Kelley, 2000), and we sought to
investigate whether such coactivation also played a role in
reconsolidation by infusing AP-5, SCH23390, and a combi-
nation of the two into the NAc immediately prior to the VR5
reactivation. We also infused MK-801 alone directly into the
NAc in order to test whether the NAc was a central locus of
action for systemic MK-801.
There were no significant differences in lever pressing
between the infusion groups during training (data not
shown; Training: F(1,24)  711.3, p  0.001
x; Treatment:
F(4,24)  0.96, p  0.447
x; Training  Treatment: F(4,24) 
0.78, p  0.550x). As there was a single common PBS
vehicle control, we conducted Bonferroni-corrected
planned comparisons between the vehicle group and
each drug group (effective p  0.0125). No treatment
group significantly differed in lever pressing from the PBS
control on the final day of training: MK-801 (F(1,10)  0.16,
p  0.700x), AP-5 (F(1,9)  0.82, p  0.389
x), SCH23390
(F(1,10)  0.03, p  0.860
x), AP-5/SCH23390 (F(1,10) 
1.13, p  0.314x). During the VR5 reactivation session, an
overall ANOVA revealed a significant effect of drug treat-
ment (F(4,24)  10.69, p  0.001
y). Planned comparisons
showed that co-infusion of AP-5 and SCH23390 immedi-
ately prior to reactivation acutely reduced lever pressing
during the VR5 session (11.3  5.9; F(1,10)  27.7, p 
0.001y); however, infusions of MK-801 (82.0  8.4; F(1,10)
 0.13, p  0.725y), AP-5 (66.6  10.6; F(1,9)  0.45, p 
0.519y) or SCH23390 (69.8  8.1; F(1,10)  0.28, p 
0.611y) alone had no acute effect compared to PBS-
infused controls (77.0  11.0).
At test, 24 h after reactivation, although an overall ANOVA
did not provide conclusive evidence for a long-term effect of
infusion (F(4,24)  2.60, p  0.06
z), planned comparisons
revealed a significant reduction in lever pressing in rats
previously infused with the AP-5/SCH23390 in combination
compared to PBS vehicle controls (Fig. 6A; F(1,10)  14.1, p
 0.004z). In contrast, similar planned comparisons did not
show any lever-pressing impairment at test in rats given
infusions of MK-801 (F(1,10)  0.05, p  0.823
z), AP-5 (F(1,9)
 0.65, p 0.441z) or SCH23390 (F(1,10) 0.03, p 0.871
z)
alone (Fig. 6A).
Mirror analysis of nosepoking responses showed similar
activity across infusion groups during training, suggesting all
groups were similarly motivated prior to reactivation (data
not shown; Training: F(1,24) 42.00, p 0.001
aa; Treatment:
F(4,24)  1.46, p  0.245
aa; Training  Treatment: F(4,24) 
0.259, p 0.901aa). Planned comparisons on the final day of
training did not reveal any significant differences in nosepok-
ing of any treatment group compared to PBS controls (MK-
801: F(1,10)  0.09, p  0.771
aa; AP-5: F(1,9)  2.36, p 
0.159aa; SCH23390: F(1,10)  0.11, p  0.746
aa; AP-5/
SCH23390: F(1,10)  2.23, p  0.166
aa).
Figure 5 MK-801 was without effect when administered prior to
a brief FR1 reactivation. A, MK-801 (n  6) and saline-treated (n
 6) groups showed no significant difference in performance at
test. B, MK-801 administration was without effect on nosepoking
at test. Data are represented as mean  SEM.
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Overall ANOVA of nosepoking during the VR5 reactiva-
tion revealed a significant acute effect of infusion (F(4,24)
8.14, p  0.001bb). Planned comparisons revealed co-
infusion of AP-5/SCH23390 acutely impaired nosepoking
at reactivation (48.8  16.7; F(1,10)  23.68, p  0.001
bb),
but infusion of MK-801 (284.3  47.3; F(1,10)  1.02, p 
0.335bb), AP-5 (161.4 22.2; F(1,9) 2.51, p 0.147
bb) or
SCH23390 (203.7  25.8; F(1,10)  0.30, p  0.596
bb)
alone had no acute effect compared to PBS controls
(213.6  36.4). This would imply that the rats co-infused
with AP-5/SCH23390 were generally less active during
the reactivation session, which may also have affected
their rate of lever pressing.
On the test session, overall ANOVA of nosepoking did
not reveal any long-term effect of prior infusion (Fig. 6B;
F(4,24)  1.42, p  0.257
cc). Planned comparisons did not
show any significant effect of any drug on nosepoking
during the test session (MK-801: F(1,10)  0.03, p 
0.875cc; AP-5: F(1,9)  5.198, p  0.049
cc; SCH23390:
F(1,10) 0.13, p 0.728
cc; AP-5/SCH23390: F(1,10) 4.51,
p  0.060cc).
Non-reactivation control
In order to test the reactivation dependence of the com-
bined AP-5/SCH23390 infusion on lever pressing, an ad-
ditional group of rats were trained and given an infusion of
PBS or AP-5/SCH23390 in the absence of any behavioral
session. Results were compared to the reactivated PBS
and AP-5/SCH23390 groups from the previous experi-
ment. If the effect of intra-NAc AP-5/SCH23390 was to
impair reconsolidation, then there should be no effect of
the infusion in the absence of behavioral reactivation
(memory destabilization).
Both reactivated and non-reactivated groups increased
their lever pressing during Training (F(1,20)  950.7, p 
0.001dd). There were no significant main effects of Treat-
ment (F(1,20)  1.93, p  0.180
dd) or Reactivation (F(1,20) 
0.20, p  0.659dd) on lever pressing during training, nor
were there any Treatment  Reactivation (F(1,20)  0.178,
p  0.678dd), Training  Treatment (F(1,20)  0.05, p 
0.824dd) or Training  Treatment  Reactivation (F(1,20) 
1.11, p  0.305dd) interactions; however, there was a
significant Training  Reactivation interaction (F(1,20) 
8.56, p  0.008dd). Analysis of lever pressing on the
second day of training showed no significant differences
between reactivated and non-reactivated infusion groups
(data not shown; Treatment: F(1,20)  1.40, p  0.250
dd;
Reactivation: F(1,20)  3.96, p  0.060
dd; Treatment 
Reactivation: F(1,20)  0.84, p  0.371
dd), indicating ex-
perimental groups were at similar levels of performance
prior to drug infusion.
Combined analysis of lever pressing at test, for both
reactivated and non-reactivated groups, revealed a
reactivation-dependent effect of AP-5/SCH23390 infusion
(Fig. 7A; Treatment  Reactivation: F(1,20)  6.82, p 
0.017ee), with no main effects of Treatment (F(1,20)  1.03,
p  0.323ee) or Reactivation (F(1,20)  0.03, p  0.868
ee).
Analysis of simple effects showed significantly reduced
lever pressing in rats infused with AP-5/SCH23390 imme-
diately prior to the VR5 reactivation compared with their
PBS-infused controls (F(1,10)  14.1, p  0.004
ee); impor-
tantly, there was no significant effect of AP-5/SCH23390
infusion on lever pressing in non-reactivated rats (F(1,10) 
0.83, p  0.385ee), suggesting reconsolidation was dis-
rupted by the infusion. Orthogonal simple effects showed
no significant difference between reactivated and non-
reactivated groups given either PBS (F(1,9)  4.44,
p0.064ee) or AP-5/SCH23390 (F(1,11)  3.22, p 
0.100ee).
Similar combined analysis of nosepoking for reacti-
vated and non-reactivated groups showed no significant
differences during training (data not shown; Training:
F(1,20)  40.44, p  0.001
ff; Treatment: F(1,20)  3.33, p 
0.083ff; Reactivation: F(1,20) 1.59, p 0.222
ff; Training
Treatment: F(1,20)  1.26, p  0.275
ff; Training  Reacti-
vation: F(1,20)  0.05, p  0.833
ff; Training  Treatment 
Reactivation: F(1,20)  1.06, p  0.315
ff), suggesting all
groups were similarly motivated prior to infusion.
Combined analysis of nosepoking at test, 24 h after
infusion, (Fig. 7B) revealed a significant reactivation-
dependent effect of AP-5/SCH23390 (Treatment  Reac-
tivation: F(1,20)  4.71, p  0.042
gg), with no main effects
of Treatment (F(1,20)  0.41, p  0.531
gg) or Reactivation
(F(1,20)  0.34, p  0.567
gg). Analysis of simple effects did
not reveal any significant differences in nosepoking be-
tween AP-5/SCH23390 and PBS-infused reactivated
Figure 6 Combined infusion of AP-5/SCH23390 significantly
impaired behavioral activity when administered immediately
prior to the VR5 reactivation. A, Coinfusion of AP-5/SCH23390 (n
 6) significantly impaired lever pressing at test compared with
PBS controls (n  6). Infusions of MK-801 (n  6), AP-5 (n  5),
or SCH23390 (n  6) alone were without significant long-term
effect on lever pressing. B, There was no significant evidence for
any long-term impairment in nosepoking with any infusion. Data
are represented as mean  SEM.
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groups (F(1,10) 4.51, p 0.060
gg), nor in non-reactivated
controls (F(1,10)  2.24, p  0.165
gg). Analysis of orthog-
onal simple effects revealed significantly reduced nose-
poking in non-reactivated PBS-infused rats compared
with their reactivated counterparts (F(1,9)  6.58, p 
0.030gg). This comparison was not significant for rats
given the combined AP-5/SCH23390 infusion (F(1,11) 
2.47, p 0.144gg). The effect on AP-5/SCH23390 infusion
on nosepoking suggests the infusion did result in impaired
motivation in some groups; however, given the
reactivation-dependence of the effect, it may have been
mediated by a reconsolidation mechanism.
Cocaine study
Using our findings from the sucrose setting, we sought to
expand our research to investigate whether a similar VR5
reactivation could be used to destabilize weakly-learned
lever-pressing memory for cocaine self-administration,
such that systemic MK-801 might impair the reconsolida-
tion of the instrumental cocaine memory and lead to a
long-term reduction in cocaine seeking.
During training, both treatment groups learned to lever
press for cocaine at similar rates with no significant dif-
ferences in performance prior to reactivation (data not
shown; Training: F(1,22)  11.23, p  0.003
hh; Treatment:
F(1,22)  0.14, p  0.708
hh; Reactivation: F(1,22)  0.46, p
 0.504hh; Treatment  Reactivation: F(1,22)  0.02, p 
0.905hh; Training  Treatment: F(1,22)  1.85, p  0.188
hh;
Training  Reactivation: F(1,22)  0.83, p  0.374
hh; Train-
ing  Treatment  Reactivation: F(1,22)  0.04, p 
0.842hh). The day after the final training session, rats were
injected with MK-801 or saline vehicle 30 min prior to
reactivation. During the VR5 reactivation, MK-801- (26.9
 2.3) and saline- (24.3  2.3) treated rats displayed
similar lever-pressing performance (F(1,12)  0.63, p 
0.444ii).
At test 24 h later (Fig. 8A), ANOVA of lever pressing
revealed a significant Treatment  Reactivation interac-
tion (F(1,22)  6.70, p  0.017
jj) with a main effect of
MK-801 Treatment (F(1,22)  9.69, p  0.005
jj), but no
main effect of Reactivation (F(1,22)  0.99, p  0.331
jj).
Analysis of simple effects showed lever pressing to be
significantly reduced in rats given MK-801 prior to the VR5
reactivation (Fig. 8A; F(1,12) 17.10, p 0.001
jj); however,
MK-801 had no effect in the absence of reactivation
(F(1,10) 0.132, p 0.724
jj), indicative of a reconsolidation
impairment. Orthogonal simple effects showed the lever
pressing of reactivated MK-801-treated rats to be signif-
icantly lower than their non-reactivated counterparts
(F(1,11)  8.19, p  0.015
jj); however, saline-treated ani-
mals showed similar lever pressing performance regard-
less of reactivation condition (F(1,11)  1.05, p  0.328
jj).
Companion analysis of nosepoking behavior was per-
formed to assess general activity during each session.
During training, ANOVA revealed a significant main effect
of Reactivation (F(1,22)  4.64, p  0.042
kk); however,
there were no other significant differences between ex-
perimental groups (Training: F(1,22)  2.80, p  0.109
kk;
Treatment: F(1,22)  0.40, p  0.533
kk; Training  Treat-
ment: F(1,22)  0.40, p  0.535
kk; Training  Reactivation:
F(1,22)  3.09, p  0.093
kk; Treatment  Reactivation:
F(1,22)  0.27, p  0.612
kk; Training  Treatment  Re-
activation: F(1,22)  0.05, p  0.829
kk). Analysis of the
second training day showed reactivated groups nose-
poked significantly more than non-reactivated controls
(F(1,22)  4.63, p  0.043
kk); however, there was no sig-
nificant difference in the number of nosepokes between
drug groups (Treatment: F(1,22) 0.47, p 0.499
kk; Treat-
ment  Reactivation: F(1,22)  0.18, p  0.680
kk). This
shows non-reactivated groups were generally less active
than their reactivated counterparts prior to injection; how-
ever, it was not specific to one treatment group.
Reactivated saline- (30.6  11.7) and MK-801- (51.0 
13.0) injected rats showed similar nosepoking perfor-
mance during the VR5 reactivation (F(1,12)  1.36, p 
0.266ll). Finally, nosepoking performance during the test
session was similar in all experimental groups (Fig. 8B;
Treatment: F(1,22)  0.004, p  0.951
mm; Reactivation:
F(1,22)  3.42, p  0.078
mm; Treatment  Reactivation:
Figure 7 The effect of combined AP-5/SCH23390 infusion to
impair responding was critically dependent on memory reactiva-
tion. A, The combined infusion significantly impaired lever press-
ing at test (as shown in Fig. 6, presented again here for clarity);
however, coadministration of AP-5/SCH23390 (n  7) did not
significantly impair lever pressing if given in the absence of
memory reactivation, compared with non-reactivated PBS in-
fused controls (n  5). B, Combined infusion of AP-5/SCH23390
also had a reactivation-dependent effect on nosepoking. Nose-
poking was moderately impaired in the reactivated infusion
group; however, the reactivation dependence of the effect is
primarily driven by low responding in the non-reactivated vehicle
group. Data are represented as mean  SEM.
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F(1,22)  0.05, p  0.823
mm), indicating there were no
significant differences in general activity during the test
session. Thus, the specific effect on lever pressing likely
represents a reduction in cocaine seeking, rather than an
overall reduction in motor activation.
Discussion
The present results demonstrate that the reconsolidation of
a weakly-trained lever-pressing memory for sucrose rein-
forcement can be disrupted by systemic, but not intra-NAc,
MK-801. By inference, the shift to a VR5 schedule was
sufficient to cause the memory to destabilize, rendering it
labile and susceptible to the amnestic effect of MK-801.
Notably, the amnestic effect of MK-801 was reactivation-
dependent, indicating the amnestic effect was due to an
impairment of reconsolidation and was specific to lever
pressing with no significant effect on nosepoking responses.
A disruption of lever pressing for sucrose was also observed
following pre-reactivation intra-NAc coinfusion of AP-5/
SCH23390, suggesting a possible role for coactivation of
accumbal D1Rs and NMDARs in the reconsolidation
process. The VR5 reactivation also proved effective in de-
stabilizing memory for cocaine self-administration, as dem-
onstrated by a systemic MK-801-induced reconsolidation
impairment. This provides an important demonstration for
the viability of reconsolidation-based therapies for maladap-
tive seeking behaviors that target the instrumental compo-
nents of memory.
Our results provide evidence that weakly-trained lever-
pressing memories undergo reactivation-induced desta-
bilization and subsequent reconsolidation under similar
conditions to well-trained instrumental memories (Exton-
McGuinness et al., 2014b). The reconsolidation of lever
pressing is shown here to be impaired by systemic MK-
801 and intra-NAc AP-5/SCH23390 administered shortly
before VR5 reactivation. The amnestic effect of these
treatments was critically dependent on memory reactiva-
tion, a key criterion for assessing reconsolidation deficits
(Dudai, 2004); treatment under inappropriate reactivation
parameters or in the absence of reactivation produced no
subsequent impairment in responding. The lack of effect
in non-reactivated controls also demonstrates that the
behavioral impairments at test were not due to any non-
specific effects of drug administration. There was a gen-
eral acute effect of systemic MK-801 to moderately
elevate responding during the reactivation sessions, sig-
nificantly so with the non-reinforced reactivation. How-
ever, this is likely explained by the hyperactivity caused at
doses used in our experiment (Hargreaves and Cain,
1995). Importantly, any acute arousing effect of MK-801 is
short-lived, as confirmed by the absence of any signifi-
cant effect at pr-STM, and cannot account for differences
observed 24 h later at test.
While the VR5 session might be expected to enhance
responding via additional learning, as lever presses were
reinforced (although at a reduced rate compared to train-
ing), there was only weak evidence for this and visual
increases in the performance of saline controls were not
statistically significant. Reactivated vehicle-treated groups
did respond moderately above the level of non-
Figure 8 Administration of MK-801, prior to a shift to a VR5 schedule
of reinforcement, significantly impaired the reconsolidation of long-
term lever pressing for cocaine self-administration in a reactivation-
dependentmanner.A, Lever pressing at test was significantly reduced
in rats administered MK-801 prior to the VR5 reactivation (n  7)
compared with both reactivated vehicle-injected rats (n  7) and the
non-reactivated MK-801-treated group (n 6). Non-reactivated vehi-
cle rats (n 6) showed similar performance to their reactivated coun-
terparts. B, Treatment with MK-801 had no significant effect on
nosepoking behavior regardless of when animals received memory
reactivation. Data are represented as mean  SEM.
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reactivated controls for both sucrose and cocaine rein-
forced memories, suggesting some degree of additional
learning, whether by a reconsolidation-mediated process
or other mechanism. However, it cannot be interpreted
that the amnestic effect of MK-801 was due solely to a
disruption of additional learning. First, non-reactivated
drug-treated groups (with no opportunity for any addi-
tional learning) responded at a similar level to reactivated
vehicle groups. Second, the deficits observed at test in
reactivated treatment-impaired groups appear to be
driven, at least in part, by a reduction in responding
compared with non-reactivated animals, consistent with a
canonical reconsolidation impairment. Furthermore, in the
cocaine setting, differences in nosepoking during training
between reactivated and non-reactivated groups may in-
dicate differences in pre-reactivation motivation, which
may have contributed to the apparent visual increase in
lever pressing in the reactivated vehicle group at test.
Finally, pr-STM following the VR5 reactivation in the
sucrose-seeking setting showed no evidence for acquisi-
tion of additional learning, nor any impairment of perfor-
mance. Intact pr-STM supports the conclusion that it was
the reconsolidation of long-term memory that was dis-
rupted by MK-801; any impairment of additional learning
during reactivation would also be expected to be ob-
served at this time point, given that MK-801 impairs the
acquisition of new memories (Gould et al., 2002; Mackes
and Willner, 2006; Alaghband and Marshall, 2013).
The reactivation-dependent nature of the lever-pressing
deficit confirms the effect of treatment was to impair
reconsolidation; however, it is not immediately clear
whether pavlovian or instrumental memory was impaired.
While instrumental memories encode associations be-
tween the behavioral response and reward, for example
lever pressing and cocaine, pavlovian associations store
information about salient environmental stimuli or con-
texts. These pavlovian memories mediate a variety of
behavioral effects, including orientating or approach to a
conditioned stimulus (Cleland and Davey, 1983), such as
a lever. Indeed, pavlovian associations are capable of
supporting the act of lever pressing when the lever, or
some aspect of the lever, acts as a conditioned stimulus
(Davey et al., 1981). Pavlovian learning can also impact
motivation and activity. While this can function to gener-
ally increase (or decrease) overall activity, it can also act
to modulate the vigor of specific instrumental behaviors
associated with a specific outcome (Dickinson and Bal-
leine, 1994; Corbit et al., 2007). Consequently, while we
might intuitively interpret reductions in lever pressing as
reconsolidation deficits in the underlying instrumental as-
sociation (Exton-McGuinness et al., 2014b), they could
equally have been mediated via disruption of pavlovian
memories that modulate instrumental behaviors; impor-
tantly, these pavlovian memories are known to undergo
reconsolidation (Lee and Everitt, 2008b; Fuchs et al.,
2009; Milton et al., 2012). In our study, nosepoke re-
sponses provide an indirect measure of pavlovian mem-
ory strength through measuring general activity (and in the
case of the sucrose studies, approach to the reward
location). Were both nosepokes and lever presses im-
paired in a reactivation-dependent manner, then it would
be highly likely that it was the reconsolidation of the
pavlovian, rather than instrumental, components of lever
pressing memory that was disrupted.
In the case of the systemic studies, using both sucrose
and cocaine reinforcement, the reactivation-dependent
effect was specific to lever pressing, with no significant
difference in nosepoking between groups. As the recon-
solidation impairment manifests only in lever pressing, it is
likely it was the instrumental memory that was disrupted
in these experiments. The selectivity of the MK-801 effect
only with the VR5 reactivation is particularly important in
this respect, given that MK-801 impairs pavlovian mem-
ory reconsolidation when reactivation consists of re-
exposure to relevant stimuli and contextual cues (Lee and
Everitt, 2008b, 2008c), with (Exton-McGuinness et al.,
2014a) or without (Reichelt and Lee, 2012) concomitant
sucrose presentation. Moreover, one would have ex-
pected pavlovian memories to have been destabilized by
the non-reinforced and FR1 reactivation conditions. How-
ever this does not appear to have been the case, sup-
porting the conclusion both that the non-reinforced and
FR1 reactivations were insufficient to cause lever-
pressing memory to destabilize, and that the impairment
with the VR5 reactivation was in instrumental memory.
In the non-reinforced reactivation condition, MK-801-
treated rats responded significantly more than vehicle
controls at test. This increase may be explained as an
impairment of extinction learning by MK-801, rather than
reconsolidation. NMDAR antagonists have previously
been shown to impair extinction (Lissek and Güntürkün,
2003; Kelamangalath et al., 2007) leading to elevated
responding at test. While brief non-reinforced sessions
are conventionally used to destabilize pavlovian memo-
ries, the fact that saline-treated animals given the non-
reinforced reactivation showed low responding compared
to both the FR1 and VR5 conditions suggests they did
extinguish during the non-reinforced reactivation, despite
its brevity. While it may be surprising that such a brief
session was sufficient to cause extinction learning, the
lever-pressing response was only weakly trained in our
experiment and thus likely easily extinguished. Given that
extinction and reconsolidation may be competing pro-
cesses (Eisenberg et al., 2003; Pedreira and Maldonado,
2003), both of which are impaired by MK-801 in appetitive
settings (Flavell and Lee, 2013), it seems unlikely that the
non-reinforced reactivation destabilized memory. How-
ever, it remains possible that shorter non-reinforced ses-
sions that do not result in extinction learning could
destabilize the instrumental memory.
The FR1 reactivation also did not destabilize the instru-
mental trace. This is important, as the destabilization
resulting from the VR5 reactivation cannot simply be at-
tributed to the presence of the reinforcer. Training trials
have been shown to destabilize fear memories (Duvarci
and Nader, 2004; Eisenberg and Dudai, 2004; Lee, 2008),
appetitive pavlovian (Rodriguez-Ortiz et al., 2005; Milekic
et al., 2006; Valjent et al., 2006), and object recognition
memories (Kelly et al., 2003; Akirav and Maroun, 2006).
However, full-length (Hernandez and Kelley, 2004) and
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brief (Mierzejewski et al., 2009) training sessions have
proved insufficient in instrumental settings, consistent
with our findings in this study. The lack of effect with the
FR1 reactivation suggests that the salient feature of the
VR5 reactivation, contributing to its ability to destabilize
instrumental memory, was the unpredictability within the
schedule. Recent studies have demonstrated that a
change in the predictability of the unconditioned stimulus
appears to be associated with increased chances of pav-
lovian memory destabilization (Díaz-Mataix et al., 2013;
Sevenster et al., 2013); this may contribute to the gener-
ation of a prediction error, believed to be required for
memories to destabilize (Exton-McGuinness et al.,
2014a). Alternatively, the change in contingency could
provide new information that may be required for initiation
of memory reconsolidation (Pedreira et al., 2004; Lee,
2009; Winters et al., 2009).
In the case of the intra-accumbal study, the precise
nature of the impairment is less clear, as there was a
reactivation-dependent effect of AP-5/SCH23390 infusion
on both lever pressing and nosepoking. While the effect
on nosepoking appears to be mostly driven by a reduction
in the non-reactivated PBS group, there does appear to
be a moderate, although inconclusive (p  0.06), reduc-
tion of nosepoking in the reactivated AP-5/SCH23390
group. Moreover, intra-accumbal MK-801 had no signifi-
cant long-term effect on behavior, suggesting both that
the NAc was not a central locus of action for systemic
MK-801 and that the effect of intra-NAc AP-5/SCH23390
was mediated by a different mechanism than that of
systemic MK-801. While the long-term effect of AP-5/
SCH23390 on lever pressing appears more severe than its
effect on nosepoking, it seems likely that the effect on
lever pressing was driven, at least in part, by a reduction
in vigor resulting from the impairment of one or more
pavlovian components of behavior. The NAc is strongly
implicated in motivation and arousal (Balleine and Kill-
cross, 1994; Cardinal et al., 2003), and the pavlovian
interpretation is further supported by the strong acute
effect of AP-5/SCH23390 at reactivation, impairing again
both lever pressing and nosepoking. The apparent per-
sistence of the impairment from reactivation to test does
not seem to be due to damage to the NAc, however, as
the effect on both lever pressing and nosepoking was
reactivation-dependent, implying the deficit did result
from a reconsolidation impairment in pavlovian memory.
If the effect of accumbal AP-5/SCH23390 was to dis-
rupt pavlovian memory reconsolidation, this raises two
questions. First, did the VR5 reactivation destabilize both
pavlovian and instrumental components of memory si-
multaneously, and did it do so in all experimental studies?
Second, why did AP-5 and SCH23390 given alone not
also impair the reconsolidation of the pavlovian memory,
given that these have previously been shown to disrupt
the consolidation of appetitive memory when infused into
the NAc (Kelley et al., 1997; Smith-Roe and Kelley, 2000;
Dalley et al., 2005)? To the first question, it seems unlikely
that both pavlovian and instrumental associations were
destabilized simultaneously, given the dose of MK-801 in
the systemic studies is well established to impair recon-
solidation of pavlovian memories (Lee et al., 2006b; Milton
et al., 2008a) and there was no evidence of a pavlovian
memory impairment in the systemic studies. It should be
noted, however, that the question of the capacity of a
single treatment to disrupt the reconsolidation of more
than one memory representation has not been adequately
addressed in the literature. Nevertheless, it is perhaps
most parsimonious to conclude that the VR5 reactivation
destabilized only the instrumental component of behavior.
In attempting to address the second question, it is
important to note that our drugs were delivered prior to
reactivation. This is a key limitation to our experimental
design, as treatments may impinge on the destabilization
of memory, as well as its reconsolidation. With this in
mind, one possibility is that, since the infusions were
given prior to reactivation, all infusions except the com-
bined AP-5/SCH23390 inhibited memory destabilization,
thus preventing reconsolidation from occurring; antago-
nism at both NMDARs (Ben Mamou et al., 2006; Milton
et al., 2013) and DR1s (Rossato et al., 2014) has been
known to inhibit destabilization. Alternatively, the effect of
the combined AP-5/SCH23390 infusion to impair pavlov-
ian memory reconsolidation may, in fact, also reflect an
enhancement of pavlovian memory destabilization during
the reactivation session, enabling its reconsolidation to be
disrupted; infusions of both AP-5 (Milton et al., 2008a; Wu
et al., 2012) and SCH23390 (Maroun and Akirav, 2009) are
known to impair reconsolidation.
While there is no independent way to assess successful
memory destabilization, other than the reconsolidation
impairment itself, the acute effect of combined AP-5/
SCH23390 during reactivation may be consistent with an
enhancement of reactivation-induced destabilization. No-
tably, the acute effect was only observed with the com-
bined infusion. Moreover, that the acute effect constituted
a performance deficit is not inconsistent with facilitated
destabilization, as successful memory expression is not
required for destabilization (Ben Mamou et al., 2006;
Rodriguez-Ortiz et al., 2012; Milton et al., 2013; Lee and
Flavell, 2014). Finally, in a pavlovian contextual fear set-
ting, it has recently been demonstrated that pharmaco-
logical treatment can stimulate memory destabilization
under behavioral conditions that, by themselves, are in-
effective (Lee and Flavell, 2014). Whether or not the hy-
pothetical enhancement of pavlovian memory
destabilization by AP-5/SCH23390 has any impact on
instrumental memory destabilization cannot be deter-
mined from our results. This, therefore, leaves open the
question of whether two independent memory traces can
be simultaneously destabilized.
While enhanced destabilization by intra-accumbal AP-
5/SCH23390 is consistent with the behavioral data, an
obvious weakness of the argument is a lack of mechanis-
tic rationale. It is well established that local NMDAR ac-
tivity is required for the reconsolidation of appetitive
(Milton et al., 2008a; Wu et al., 2012) and aversive
(Campeau et al., 1992; Rodrigues et al., 2001; Goosens
and Maren, 2004; Lee and Hynds, 2013; Milton et al.,
2013) pavlovian memories. Furthermore, existing evi-
dence indicates that that antagonism of NMDARs blocks,
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rather than enhances, destabilization (Ben Mamou et al.,
2006; Milton et al., 2013). While there is less evidence that
D1R antagonism impairs reconsolidation (Sherry et al.,
2005; Diergaarde et al., 2008; Maroun and Akirav, 2009),
there is also a report of D1R antagonism disrupting the
destabilization of object recognition memory (Rossato
et al., 2014). Additionally, dysregulation of dopaminergic
midbrain neurons prevents appetitive memory destabili-
zation (Reichelt et al., 2013). Therefore, within such a
literature and framework, there is little reason to suggest
that antagonism of NMDARs or D1Rs might enhance
memory destabilization. That said, infusion of AP-5 and
SCH23390 individually did not result in the putative en-
hancement of memory destabilization.
While speculative, our data may imply that combined,
but not individual, antagonism of D1Rs and NMDARs
enhances destabilization of appetitive pavlovian memory,
rather than preventing it. A growing body of evidence
suggests NMDARs functionally interact with G-protein-
coupled receptors, like D1Rs (for review, see Fan et al.,
2014). While some of this interaction is mediated by con-
vergent signaling pathways, there also appears to be a
subunit-specific direct proteinprotein interaction be-
tween D1Rs and NMDARs (Lee et al., 2002; Pei et al.,
2004). Interestingly, activation of the D1R can facilitate bind-
ing of the calcium-sensor calmodulin (CaM) to the NR1
subunit of the NMDAR (Lee and Liu, 2004), leading to acti-
vation of a variety of downstream signaling molecules, in-
cluding CaM-dependent kinase II (CaMKII). Notably, CaMKII
has been implicated in the induction of both long-term po-
tentiation and depression; the switch between the two ap-
pears to be determined by the precise phosphorylation state
of specific sites (Pi et al., 2010), affecting the substrate
selection of CamKII (Coultrap et al., 2014). Importantly,
CaMKII also appears to be important in recruitment of the
proteasome pathway (Bingol et al., 2010), which is critical in
memory destabilization (Lee et al., 2008). By appealing to
such a literature, we can speculate that co-antagonism of
D1Rs and NMDARs may have biased intracellular signaling
pathways, such as CaMKII, towards conditions that favor
protein degradation and memory destabilization. Given that
many cellular pathways involved in consolidation, destabili-
zation, and reconsolidation appear to be shared, investiga-
tion of how specific surface-receptor subunits interact may
prove a fruitful avenue to explore to understand how these
pathways diverge.
Returning to the systemic MK-801 experiments, it is
notable that similar effects were observed in both the
sucrose and cocaine settings. In previous studies of pav-
lovian memory reconsolidation, important differences
have been observed in the reconsolidation of cue–su-
crose and cue–cocaine memories. For example, the cue–
cocaine memory was more easily destabilized by
noncontingent cue exposure than was the cue–sucrose
memory (Lee et al., 2006a; Lee and Everitt, 2008a). Here,
it is not clear whether sucrose and cocaine instrumental
memories have identical destabilization parameters. The
common capacity of the VR5 reactivation to destabilize
the instrumental memory may, in fact, reflect differential
parameters, as the acquisition data were clearly different
between the two experiments. The mean number of total
sucrose reinforcements across all experiments was 71.0,
compared with 37.7 in the cocaine experiment. Therefore,
it is possible that with matched training conditions, instru-
mental memories for sucrose and cocaine reinforcement
may require different reactivation parameters for success-
ful destabilization. Nevertheless, the fundamental conclu-
sion that instrumental cocaine memories can be disrupted
by targeting their reconsolidation has potential value for
translational exploitation in the treatment of compulsive
cocaine-seeking behavior. It remains to be determined,
however, whether the reconsolidation of well-learned in-
strumental cocaine memories can be disrupted, as has
previously been demonstrated for sucrose (Exton-
McGuinness et al., 2014b).
In summary, our results demonstrate that weakly-
trained instrumental memories for both sucrose and co-
caine reinforcement do destabilize following a shift to a
variable ratio schedule, and their reconsolidation can be
disrupted by systemic MK-801. Interestingly, the NAc
does not appear to be a central locus of action for MK-
801; however, coactivation of D1Rs and NMDARs in the
NAc may play a role in both the destabilization and re-
consolidation of the pavlovian components associated
with lever-pressing behavior. Importantly, our data pro-
vide evidence that instrumental memory reconsolidation
can be disrupted to diminish cocaine seeking. This pro-
vides strong support for the viability of novel
reconsolidation-based therapies to diminish maladaptive
behaviors such as drug addiction.
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